- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
NATIONWIDE SURVEY ON HEMATOPOIETIC STEM CELL HARVEST AND OTHER APHERESIS IN JAPAN
-
- Yakushijin Kimikazu
- Department of Medical Oncology and Hematology, Kobe University Hospital Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Yoshihara Satoshi
- Department of Hematology, Hyogo Medical University Hospital Department of Transfusion and Cellular Therapy, Hyogo Medical University Hospital Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Ikemoto Junko
- Department of Transfusion and Cellular Therapy, Hyogo Medical University Hospital
-
- Ikeda Kazuhiko
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Ishida Akaru
- Division of Transfusion Medicine and Cell Transplantation, Saitama Medical University International Medical Center Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Ohto Hitoshi
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Ohara Akira
- Toho University Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Kajiwara Michiko
- Center for Transfusion Medicine and Cell Therapy, Tokyo Medical and Dental University Hospital Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Kikuta Atsushi
- Department of Pediatric Oncology, Fukushima Medical University Hospital Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Haraguchi Kyoko
- Division of Transfusion and Cell Therapy, Tokyo Metropolitan Komagome Hospital Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Fujiwara Shin-ichiro
- Division of Cell Transplantation and Transfusion, Jichi Medical University Hospital Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Yamada-Fujiwara Minami
- Division of Blood Transfusion and Cell Therapy, Tohoku University Hospital Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Yamazaki Rie
- Center for Transfusion Medicine and Cell Therapy, Keio University School of Medicine Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Nagamura-Inoue Tokiko
- Department of Cell Processing and Transfusion, The Institute of Medical Science, The University of Tokyo Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Tanosaki Ryuji
- Center for Transfusion Medicine and Cell Therapy, Keio University School of Medicine Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Okuyama Yoshiki
- Division of Transfusion and Cell Therapy, Tokyo Metropolitan Komagome Hospital Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Fujimori Yoshihiro
- Department of Transfusion and Cellular Therapy, Hyogo Medical University Hospital Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
-
- Ueda Yasunori
- Department of Hematology/Oncology, Kurashiki Central Hospital Cytapheresis Working Group, The Japan Society of Transfusion Medicine and Cell Therapy
Bibliographic Information
- Other Title
-
- 本邦における造血幹細胞採取等のアフェレーシスの実態調査
Search this article
Description
<p>Peripheral blood stem cell harvesting (PBSCH) is an established general practice; however, recent medical advances have led to diversification in hematopoietic stem cell transplantation and collection. A questionnaire survey on cell therapy and blood cell apheresis was conducted to understand the current situation and identify issues in Japan. A total of 159 facilities/departments responded to the survey. The annual number of autologous PBSCH was "11-25" in 48% and "1-10" in 37% of the centers, while the annual number of allogeneic PBSCH for related transplantation was "1-10" in 60% of the centers and "1-10" in 50% for unrelated transplantation. Collection sites were in the wards (40%), transfusion department (36%), and dialysis unit (26%). The apheresis system was staffed mainly by clinical engineers (67%) and doctors (23%). Primarily, doctors (96%) performed peripheral vascular punctures and were present at all times during collection in 37% of the centers. The Spectra Optia was the equipment most commonly used for apheresis. To freeze the product, 89% of the centers used "CP-1" without a controlled rate freezer. This survey revealed the diversification of collection methods in Japan, with "task shift" emerging as a significant concern.</p>
Journal
-
- Japanese Journal of Transfusion and Cell Therapy
-
Japanese Journal of Transfusion and Cell Therapy 69 (6), 641-647, 2023-12-20
The Japan Society of Transfusion Medicine and Cell Therapy
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390298764873773440
-
- ISSN
- 18830625
- 18813011
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- OpenAIRE
-
- Abstract License Flag
- Disallowed